Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether the addition of panitumumab to
radiotherapy plus gemcitabine will increase the number of patients who are alive and
progression free at 7 months.